By PTI
NEW DELHI: The alleged position of Indian pharma firms within the deaths of youngsters overseas led to a verbal tussle between the BJP and the Congress on Thursday.
While the opposition occasion requested the federal government to cease boasting about India being a pharmacy to the world and take strictest motion, the ruling occasion accused it of deriding India in its “hate” for Prime Minister Narendra Modi.
The Central Drugs Standard Control Organisation (CDSCO) has initiated a probe in reference to the demise of 18 youngsters in Uzbekistan allegedly linked to a cough syrup manufactured by an Indian agency, official sources stated on Thursday. Before that, have been experiences linking the deaths of youngsters in Gambia to India-made cough syrups.
The Drugs Controller General of India had claimed the WHO drew a untimely hyperlink.
“Made in India cough syrups seem to be deadly. First, it was the deaths of 70 kids in Gambia & now it is that of 18 children in Uzbekistan. Modi Sarkar must stop boasting about India being a pharmacy to the world & take strictest action,” Congress normal secretary Jairam Ramesh stated on Twitter.
ALSO READ | ‘Shocked, deeply saddened,’ says Maiden pharma after WHO alert on its cough syrups hyperlinks to baby deaths in Gambia
The BJP hit again with its IT division in-charge Amit Malviya replying, “The death of children in Gambia had nothing to do with the consumption of cough syrup made in India. That has been clarified by the Gambian authorities and DCGI, both. But blinded in its hate for Modi, Congress continues to deride India and its entrepreneurial spirit. Shameful.”
The DCGI stated Gambia has knowledgeable, in response to media, that there was no direct causal relation established but between cough syrup consumption and the deaths, and that sure youngsters who had died had not consumed the syrup in query.
The well being ministry of Uzbekistan has claimed that the 18 youngsters had consumed cough syrup, ‘Doc-1 Max’, manufactured by Noida-based Marion Biotech.
NEW DELHI: The alleged position of Indian pharma firms within the deaths of youngsters overseas led to a verbal tussle between the BJP and the Congress on Thursday.
While the opposition occasion requested the federal government to cease boasting about India being a pharmacy to the world and take strictest motion, the ruling occasion accused it of deriding India in its “hate” for Prime Minister Narendra Modi.
The Central Drugs Standard Control Organisation (CDSCO) has initiated a probe in reference to the demise of 18 youngsters in Uzbekistan allegedly linked to a cough syrup manufactured by an Indian agency, official sources stated on Thursday. Before that, have been experiences linking the deaths of youngsters in Gambia to India-made cough syrups.
The Drugs Controller General of India had claimed the WHO drew a untimely hyperlink.
“Made in India cough syrups seem to be deadly. First, it was the deaths of 70 kids in Gambia & now it is that of 18 children in Uzbekistan. Modi Sarkar must stop boasting about India being a pharmacy to the world & take strictest action,” Congress normal secretary Jairam Ramesh stated on Twitter.
ALSO READ | ‘Shocked, deeply saddened,’ says Maiden pharma after WHO alert on its cough syrups hyperlinks to baby deaths in Gambia
The BJP hit again with its IT division in-charge Amit Malviya replying, “The death of children in Gambia had nothing to do with the consumption of cough syrup made in India. That has been clarified by the Gambian authorities and DCGI, both. But blinded in its hate for Modi, Congress continues to deride India and its entrepreneurial spirit. Shameful.”
The DCGI stated Gambia has knowledgeable, in response to media, that there was no direct causal relation established but between cough syrup consumption and the deaths, and that sure youngsters who had died had not consumed the syrup in query.
The well being ministry of Uzbekistan has claimed that the 18 youngsters had consumed cough syrup, ‘Doc-1 Max’, manufactured by Noida-based Marion Biotech.
